These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Research and therapeutic trials on gliomas]. Ducray F Soins; 2009 Mar; (733):51. PubMed ID: 19366007 [No Abstract] [Full Text] [Related]
5. Defining the standard of care for high-grade glioma--a NICE deal for UK patients? Khanduri S; Gerrard G Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):507-8. PubMed ID: 17618095 [No Abstract] [Full Text] [Related]
6. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Kaloshi G; Benouaich-Amiel A; Diakite F; Taillibert S; Lejeune J; Laigle-Donadey F; Renard MA; Iraqi W; Idbaih A; Paris S; Capelle L; Duffau H; Cornu P; Simon JM; Mokhtari K; Polivka M; Omuro A; Carpentier A; Sanson M; Delattre JY; Hoang-Xuan K Neurology; 2007 May; 68(21):1831-6. PubMed ID: 17515545 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of malignant gliomas in the elderly]. Uzuka T; Tanaka R; Takahashi H Nihon Rinsho; 2005 Sep; 63 Suppl 9():591-5. PubMed ID: 16201586 [No Abstract] [Full Text] [Related]
9. [Pattern of care of high-grade gliomas]. Laigle-Donadey F; Sanson M Rev Prat; 2006 Oct; 56(16):1779-86. PubMed ID: 17315503 [TBL] [Abstract][Full Text] [Related]
10. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation. Schiff D Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745 [TBL] [Abstract][Full Text] [Related]
11. [Latest treatment strategies for malignant gliomas]. Shono T; Mizoguchi M; Sasaki T Fukuoka Igaku Zasshi; 2007 Sep; 98(9):333-6. PubMed ID: 17974076 [No Abstract] [Full Text] [Related]
12. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics]. Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141 [TBL] [Abstract][Full Text] [Related]
13. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Stupp R; Tonn JC; Brada M; Pentheroudakis G; Ann Oncol; 2010 May; 21 Suppl 5():v190-3. PubMed ID: 20555079 [No Abstract] [Full Text] [Related]
14. Glioma therapy in adults. Norden AD; Wen PY Neurologist; 2006 Nov; 12(6):279-92. PubMed ID: 17122724 [TBL] [Abstract][Full Text] [Related]
15. Neurocognitive functioning in patients of high-grade gliomas. Ladislav S J Cancer Res Ther; 2013; 9(4):757-8. PubMed ID: 24518741 [No Abstract] [Full Text] [Related]
16. FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation. Pinkham MB; Telford N; Whitfield GA; Colaco RJ; O'Neill F; McBain CA Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):445-53. PubMed ID: 25971646 [TBL] [Abstract][Full Text] [Related]
17. Intraoperative pathological diagnosis in 205 glioma patients in the pre-BCNU wafer era: retrospective analysis with intraoperative implantation of BCNU wafers in mind. Ishikawa E; Yamamoto T; Satomi K; Matsuda M; Akutsu H; Shibuya M; Nakai K; Sakamoto N; Takano S; Matsumura A Brain Tumor Pathol; 2014 Jul; 31(3):156-61. PubMed ID: 24535160 [TBL] [Abstract][Full Text] [Related]
19. Is protracted low-dose temozolomide feasible in glioma patients? Wong ET Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133 [No Abstract] [Full Text] [Related]
20. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]